Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Efficacy Study of Antimalarial Drugs in Children With Uncomplicated Falciparum Malaria in Uganda
PACTR201811640750761Phase 4Recruiting
- Sponsor
- United States Agency for International Development
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dihydroartemisinin + piperaquine, artesunate + amodiaquine and artemether + lumefantrine in Malaria, sponsored by United States Agency for International Development. Primary endpoints: Early treatment failure, Late clinical failure and 3 more. Started Mar 2018; status: recruiting.
02
Drugs
dihydroartemisinin + piperaquineartesunate + amodiaquineartemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR201811640750761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201811640750761.